Phase 3 Bronchopulmonary Dysplasia Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Bronchopulmonary Dysplasia
Airway Therapeutics, Inc.366 enrolled20 locationsNCT06897839
Suspended
Phase 2Phase 3
The Torpido2 Study: Targeted Oxygenation in the Respiratory care of Premature Infants at Delivery: Effects on developmental Outcome
Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation of premature infants+2 more
University of Sydney1,200 enrolled5 locationsACTRN12615000115538
Recruiting
Phase 2Phase 3
The To2rpido Study: Targeted Oxygenation in the Resuscitation of Premature Infants and their Developmental Outcome
Oxidative stress in premature infantsBronchopulmonary dysplasia in premature infantsResuscitation in premature infants+1 more
The Royal Hospital for Women1,892 enrolled1 locationACTRN12610001059055